- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06872749
Effect of an Experimental Gel Containing Copaiba Oil-resin in the Control of Dentin Hypersensitivity
Effect on an Experimental Gel Containing Copaiba Oil-resin in the Control of Dentin Hypersensitivity: a Randomized Clinical Study
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The sequence of application of the gels, whether active or placebo, will be as follows:
A professional prophylaxis will be performed using a rubber cup on the dental elements. The corresponding gel for each group will be applied with the aid of a micro-applicator and will remain undisturbed on the surface for 10 minutes. After the gel application time has elapsed, and while it is still on the teeth, the product will be rubbed with a micro-applicator using circular and intermittent movements. Subsequently, the gel will be removed with cotton and abundant water.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Pará
-
Belém, Pará, Brazil
- Universidade Federal do Pará
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- hypersensitive areas on the vestibular surface of the teeth with exposed cervical dentin up to 1 mm deep and/or class I gingival recession according to the Miller classification;
- individuals who have at least two hypersensitive teeth
- periodontal health,
- good general physical health;
- willingness to participate in the research by providing written informed consent;
- no eating disorders or very acidic diets
Exclusion Criteria:
- presence of restorations;
- presence of dental caries and periodontal pockets;
- ongoing treatment with antibiotics and/or anti-inflammatory and/or analgesic drugs;
- professional desensitizing treatment received three months prior to the study;
- pregnancy or lactation; systemic diseases;
- pulpitis;
- use of orthodontic appliances or dental prostheses that may interfere with the assessment of hypersensitivity
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Placebo Comparator: Placebo gel
the group will receive the application of gel without active ingredient
|
will receive the application of a placebo gel (without active ingredient), under the same conditions described for the experimental gel.
|
|
Active Comparator: KF2 (Potassium nitrate gel)
the group will receive the application of gel containing potassium nitrate
|
will receive application of potassium nitrate gel on hypersensitive dental surfaces, in an active way, for 10 minutes.
|
|
Experimental: Copaiba gel
the group will receive the application of gel containing copaiba
|
will receive the application of the experimental desensitizing gel on the vestibular surfaces of the hypersensitive teeth in an active manner, for 10 minutes.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
sensitivity assessment
Time Frame: 30 days
|
Evaluation of hypersensitivity in teeth with non-carious cervical lesions.
Patients will be instructed to complete a form to record tooth sensitivity before the application of the gels.
An evaluation will be performed at baseline, 7 days, 15 days and 30 days, based on their individual perception of pain.
The evaluation form will consist of a visual analogue scale (VAS).
This scale consists of a 10 cm horizontal line with points of 0 and 10 at its ends, where 0 means no sensitivity and 10 means severe tooth sensitivity.
The patient will be instructed to draw a vertical line along the horizontal line of the scale, recording the intensity of tooth sensitivity.
So that the distance in millimeters from the zero end can later be measured with the aid of a millimeter ruler, thus obtaining the intensity level of the patient's back.
|
30 days
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Cecy M Silva, Doctor, Universidade Federal do Pará
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 6.787.218
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.